European producers of food and household goods are confronting a fresh phase of inflationary pressure that, according to Barclays, is manifesting differently to the disruption seen in 2022-23. Companies report better hedging and more resilient supply chains, yet oil-linked input costs are accelerating once again and consumers remain worn down after several years of price increases.
Barclays argues that the current backdrop is increasingly a test of operational execution, portfolio mix and brand strength. The bank identifies firms that can sustain or grow volumes, occupy structurally advantaged categories and credibly deliver on savings and pricing as the most attractive in this environment.
Unilever
Barclays regards Unilever as among the best positioned in the sector. The bank notes that much of Unilever's inflationary impact has been contained primarily within its Home Care division in Emerging Markets, where the company benefits from stronger structural pricing power. At the same time, Unilever's higher-margin units are facing a relatively more benign cost environment, which supports a favorable earnings mix.
In other developments, Unilever held discussions with Kraft Heinz about a potential merger of their food brands, but those talks ended prior to February.
L'Oréal
Barclays describes L'Oréal as the highest-quality compounder in the space. The bank highlights the company's ongoing market-share gains and a strengthening competitive position driven by leadership in digital capabilities, applications of artificial intelligence and continued product innovation. Barclays cautions, however, that much of this operational strength is already reflected in the stock's valuation.
Separately, Exane BNP Paribas upgraded L'Oréal to neutral from underperform, citing the group's strong ability to manage inflationary pressures.
Haleon
Barclays views Haleon as offering one of the most asymmetric risk-reward profiles within the sector. The bank points out that two weak cough and cold seasons have obscured visible improvements in U.S. execution, momentum in Oral Health categories and gains in shelf space. Haleon benefits from limited exposure to oil-linked input costs and stands to leverage earnings per share from ongoing cost savings programs.
Haleon has also been active in returning capital to shareholders through a share buyback program, having purchased and cancelled several million ordinary shares.
Danone
Barclays says Danone's valuation has been under pressure, largely driven by uncertainty over the pace of recovery in its U.S. Essential Dairy and Plant-based business and by recent Infant Formula recalls, rather than by problems with the group's core growth drivers. The bank highlights Medical Nutrition as an emerging, high-quality contributor to profit and expects overall growth to re-accelerate in the second half of the year, making current valuation levels more appealing.
Bank of America’s analysis of Nielsen data for the four weeks ending March 22 showed a slip for Danone in the European food market.
Barclays' framework for selection
Across the names it favors, Barclays places a premium on demonstrable volume momentum, categorization in structurally advantaged segments and a credible delivery track record on cost and growth measures. The bank suggests these attributes are the most relevant for navigating the current mix of oil-linked cost pressure and subdued consumer spending.
This article presents Barclays' view on which European food and household stocks are best-placed for the current market environment, summarizing the bank's rationale for selecting Unilever, L'Oréal, Haleon and Danone.